These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4156547)

  • 1. Inhibition of gastric acid secretion in the rat by orally-administered synthetic prostaglandin analogues: enantiomorphs of 15-hydroxy-15-methyl-9-oxoprostanoic acid.
    Lippmann W
    J Pharm Pharmacol; 1974 Oct; 26(10):831-3. PubMed ID: 4156547
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral antigastric acid secretory activity of synthetic prostaglandin analogues (9-oxoprostanoic acids).
    Lippmann W
    Experientia; 1973 Aug; 29(8):990-1. PubMed ID: 4733330
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral gastric acid secretion-inhibitory activity and anti-ulcer activity of synthetic prostaglandin analogues: C-15 epimers of 15-hydroxy-15-methyl-9-oxoprostanoic acid (AY-22,469).
    Lippmann W
    Prostaglandins; 1974 Aug; 7(3):223-9. PubMed ID: 4414938
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxyprostaglandin analogues: 15-hydroxy-16,16-dimethyl-9-oxoprost-5,13-dienoic acids.
    Lippmann W
    Prostaglandins; 1974 Aug; 7(3):231-46. PubMed ID: 4413891
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion.
    Karim SM; Carter DC; Bhana D; Ganesan PA
    Br Med J; 1973 Jan; 1(5846):143-6. PubMed ID: 4706806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins and congeners. Synthesis of simplified prostaglandins. Inhibition of gastric acid secretion by 2-(omega-carboxyalkyl)-3-alkylcycloalkanones.
    Poletto JF; Bernady KF; Kupfer D; Partridge R; Weiss MJ
    J Med Chem; 1975 Apr; 18(4):359-62. PubMed ID: 1121001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gastric acid secretion in the rat by synthetic prostaglandin analogues.
    Lippmann W
    Ann N Y Acad Sci; 1971 Apr; 180():332-5. PubMed ID: 5286101
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins.
    Whittle BJ
    Eur J Pharmacol; 1976 Dec; 40(2):233-9. PubMed ID: 11107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of orally and intravenously administered prostaglandin 16:16 dimethyl E2 methyl ester on human gastric acid secretion.
    Karim SM; Carter DC; Bhana D; Ganesan PA
    Prostaglandins; 1973 Jul; 4(1):71-83. PubMed ID: 4728438
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral anti-ulcer activity of a synthetic prostaglandin analogue (9-oxoprostanoic acid: AY-22,469).
    Lippmann W; Seethaler K
    Experientia; 1973 Aug; 29(8):993-5. PubMed ID: 4733332
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of gastric acid secretion in the rat by synthetic prostaglandins.
    Lippmann W
    J Pharm Pharmacol; 1969 May; 21(5):335-6. PubMed ID: 4390134
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of gastric acid secretion by a potent synthetic prostaglandin.
    Lippmann W
    J Pharm Pharmacol; 1970 Jan; 22(1):65-7. PubMed ID: 4391752
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of human gastric secretion by prostaglandin.
    Carter DC; Karim SM; Bhana D; Ganesan PA
    Br J Surg; 1973 Oct; 60(10):828-31. PubMed ID: 4748390
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of orally administered prostaglandins A1, A2 and 15 EPI-A2 on human gastric acid secretion.
    Bhana D; Karim SM; Carter DC; Ganesan PA
    Prostaglandins; 1973 Mar; 3(3):307-16. PubMed ID: 4729574
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of indomethacin-induced gastric ulceration in the rat by perorally-administered synthetic and natural prostaglandin analogues.
    Lippmann W
    Prostaglandins; 1974 Jul; 7(1):1-10. PubMed ID: 4852476
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of orally administered prostaglandin E1 on gastric secretion and gastrointestinal motility in man.
    Horton EW; Main IH; Thompson CJ; Wright PM
    Gut; 1968 Dec; 9(6):655-8. PubMed ID: 5717966
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and biological activity of prostaglandins and prostaglandin antagonists.
    Fried J; Lin C; Mehra M; Kao W; Dalven P
    Ann N Y Acad Sci; 1971 Apr; 180():38-63. PubMed ID: 4999659
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric secretory inhibition induced by three methyl analogs of prostaglandin E2 administered intragastrically to man.
    Nylander B; Andersson S
    Scand J Gastroenterol; 1974 Nov; 9(8):751-8. PubMed ID: 4432046
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of gastric acid secretion in vitro by prostaglandin E1.
    Way L; Durbin RP
    Nature; 1969 Mar; 221(5183):874-5. PubMed ID: 4303810
    [No Abstract]   [Full Text] [Related]  

  • 20. E-type prostaglandins and gastric acid secretion in the rat.
    Banerjee AK; Phillips J; Winning WM
    Nat New Biol; 1972 Aug; 238(84):177-9. PubMed ID: 4505987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.